chartexchange

MIRM
Mirum Pharmaceuticals, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 3:44:37 PM EST
95.77USD+3.546%(+3.28)521,271
Pre-marketNov 19, 2026 9:27:30 AM EST
92.40USD-0.097%(-0.09)
80.77Bid96.14Ask15.37Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Foster City, CA, USA
Previous Close
$92.49
Beta
1.09
52-Week High
$130.00 2026-07-09
52-Week Low
$63.23 2025-12-15
SMA 50
$88.34
SMA 200
$98.23
Avg. Vol 10D
556,514
Avg. Vol 30D
646,642
Avg. Vol 90D
682,359
Relative Vol
0.80
54.08M
0.4100%
MIRM Profile

mirum pharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. its lead product candidate is maralixibat, an investigational oral drug that is in phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of alagille syndrome and biliary atresia disease. the company is also develops volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. mirum pharmaceuticals, inc. was founded in 2018 and is headquartered in foster city, california.

MIRM Performance
PeriodPriceDateChangeBeta
1W93.332026-11-12+2.65%1.953
1M82.242026-10-19+16.49%1.220
3M102.242026-08-19-6.29%1.079
6M95.652026-05-19+0.16%0.710
1Y70.442025-11-19+36.02%1.087
2Y42.092024-11-19+127.62%—
5Y15.692021-11-19+510.61%0.748
MIRM Stock Summary

Mirum Pharmaceuticals, Inc. Common Stock (NASDAQ:MIRM) stock price today is $95.81, and today's volume is 520,387. MIRM is up 3.584% today. The 30 day average volume is 646,642. MIRM market cap is $6.25B with 65.28M shares outstanding.